19.05.2015 • News

Siltronic Aims for Stock Listing Before Summer

Siltronic, electronics subsidiary of Munich-based Wacker Chemie and the world's third-largest maker of the silicon wafers used in semiconductor chips, aims to raise more than €150 million from an initial public offering planned to take place before the European summer holidays.

The German wafers producer said it will issue new shares as part of an equity increase, while parent Wacker will separately sell existing shares in the company to private and institutional investors on the German and Luxembourg stock market. Shares also will be offered for subscription in private placements outside the stock market.

Wacker intends to retain a majority stake in the electronics offshoot, at least for the short term.

Siltronic said it would use proceeds from the listing to reduce its debt. In a statement, CEO Christoph von Plotho said the company has "worked hard" to prepare for the ipo, implementing cost cuts totaling €135 million over the past two years.

Like its rivals in other countries, foremostly Japan, the Munich company has struggled with falling prices for silicon as personal computer markets have matured, limiting demand for microchips.

The worldwide silicon wafer market peaked at around $12.5 billion in 2007 but sales have plunged by more than a third since then, according to figures compiled by Gartner Inc. The market collapse has triggered a wave of consolidation in the global industry, necessitating plant closures at Siltronic.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.